You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
|
|---|---|
| Published in |
New England Journal of Medicine, March 2023
|
| DOI | 10.1056/nejmoa2215024 |
| Pubmed ID | |
| Authors |
Steven E Nissen, A Michael Lincoff, Danielle Brennan, Kausik K Ray, Denise Mason, John J P Kastelein, Paul D Thompson, Peter Libby, Leslie Cho, Jorge Plutzky, Harold E Bays, Patrick M Moriarty, Venu Menon, Diederick E Grobbee, Michael J Louie, Chien-Feng Chen, Na Li, LeAnne Bloedon, Paula Robinson, Maggie Horner, William J Sasiela, Jackie McCluskey, Deborah Davey, Pedro Fajardo-Campos, Predrag Petrovic, Jan Fedacko, Witold Zmuda, Yury Lukyanov, Stephen J Nicholls |
X Demographics
The data shown below were collected from the profiles of 1,139 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 164 | 14% |
| Spain | 68 | 6% |
| Thailand | 62 | 5% |
| United Kingdom | 29 | 3% |
| India | 21 | 2% |
| Australia | 20 | 2% |
| Canada | 16 | 1% |
| Mexico | 16 | 1% |
| Italy | 12 | 1% |
| Other | 155 | 14% |
| Unknown | 576 | 51% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 851 | 75% |
| Practitioners (doctors, other healthcare professionals) | 133 | 12% |
| Scientists | 130 | 11% |
| Science communicators (journalists, bloggers, editors) | 25 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 293 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 293 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 32 | 11% |
| Other | 29 | 10% |
| Unspecified | 23 | 8% |
| Student > Doctoral Student | 22 | 8% |
| Student > Bachelor | 20 | 7% |
| Other | 53 | 18% |
| Unknown | 114 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 100 | 34% |
| Unspecified | 22 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 6% |
| Biochemistry, Genetics and Molecular Biology | 10 | 3% |
| Chemistry | 3 | 1% |
| Other | 14 | 5% |
| Unknown | 125 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3032. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2024.
All research outputs
#2,191
of 25,805,386 outputs
Outputs from New England Journal of Medicine
#152
of 32,690 outputs
Outputs of similar age
#51
of 427,150 outputs
Outputs of similar age from New England Journal of Medicine
#2
of 273 outputs
Altmetric has tracked 25,805,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,690 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,150 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.